New injectable filler adipearl tested for safety in small pilot study
NCT ID NCT06322043
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study is testing the safety of Adipearl, an injectable filler designed to restore volume in the face. Researchers are enrolling 18 adults aged 22 to 65 with face volume deficiency. The main goal is to monitor injection site reactions and other side effects over the study period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Adipearl (injectable filler)
- What this could lead to
- If safe, Adipearl could offer a new option for restoring facial volume, potentially improving appearance and confidence.
- What could go wrong
- This is a very small, early safety study with only 18 participants. It does not yet measure effectiveness, and side effects like injection reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACE VOLUME DEFICIENCY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Summit Clinic
Crans-Montana, Switzerland